Weijing Sun

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Metastatic Colorectal Cancer

Top Venues

Nature communications

Journal of medical Internet research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Ian M Freed, Anup Kasi, Oluwadamilola Fateru, Mengjia Hu, Phasin Gonzalez, Nyla Weatherington, Harsh Pathak, Stephen Hyter, Weijing Sun, Raed Al-Rajabi, Joaquina Celebre Baranda, Mateusz L Hupert, Prabhakar Chalise, Andrew K Godwin, Malgorzata A Witek, Steven A Soper
Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. Cells 12 (18) (2023)
Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun, Shanshan Weng
CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice. Cancer biology & medicine (2023)
Weijing Sun, Nirmal Veeramachaneni, Raed Al-Rajabi, Rashna Madan, Anup Kasi, Mazin Al-Kasspooles, Joaquina Baranda, Anwaar Saeed, Milind A Phadnis, Andrew K Godwin, Mojtaba Olyaee, Natalie Streeter, Alykhan Nagji, Junqiang Dai, Stephen Williamson
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma. Cancer medicine (2023)
Prabhu Ramamoorthy, Sufi Mary Thomas, Gaurav Kaushik, Dharmalingam Subramaniam, Katherine M Chastain, Animesh Dhar, Ossama Tawfik, Anup Kasi, Weijing Sun, Satish Ramalingam, Sumedha Gunewardena, Shahid Umar, Joshua M Mammen, Subhash B Padhye, Scott J Weir, Roy A Jensen, G Sitta Sittampalam, Shrikant Anant
Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response. Cancer research 79 (7) (2019)
Michael A Morse, Weijing Sun, Richard Kim, Aiwu Ruth He, Paolo B Abada, Michelle Mynderse, Richard S Finn
The Role of Angiogenesis in Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (3) (2018)
Weijing Sun, Anuj Patel, Daniel Normolle, Krishna Patel, James Ohr, James J Lee, Nathan Bahary, Edward Chu, Natalie Streeter, Summer Drummond
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma. Cancer 125 (6) (2018)
Weijing Sun
Recent advances in cancer immunotherapy. Journal of hematology & oncology 10 (1) (2017)
Carissa A Low, Anind K Dey, Denzil Ferreira, Thomas W Kamarck, Weijing Sun, Sang Won Bae, Afsaneh Doryab
Estimation of Symptom Severity During Chemotherapy From Passively Sensed Data: Exploratory Study. Journal of medical Internet research 19 (12) (2017)